Skip to main content
Premium Trial:

Request an Annual Quote

UT Molecular Medical Center Taps GenoLogics for Translational Research Software

NEW YORK (GenomeWeb News) – A University of Texas medical research center will collaborate with GenoLogics to develop an integrated software solution for use in its translational medical bioinformatics research programs, GenoLogics said today.
 
The Vancouver, British Columbia-based company said it will work with the Sealy Center for Molecular Medicine at the University of Texas Medical Branch at Galveston to develop biospecimen-management software.
 
The SCMM, which is part of the Institute for Translational Sciences, is focused on developing new tools for studying biomarkers and human diseases at the molecular level.
 
“In order to validate our biomarkers for common diseases, we needed to exchange information from clinical to research domains,” SCMM’s director of Biomarker Discovery, Kevin Rosenblatt, said in a statement. 
 
To do that, Rosenblatt said, SMCC sought “a biomedical informatics solution that not only tracks our biospecimens, but also the clinical annotations and then connects to the data being generated in our research labs.”
 
The system that the company and the center develop will “bring it all together in a single platform,” he added.

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.